Gilotrif and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gilotrif (afatinib dimaleate) and Lantus (insulin glargine recombinant). Common drug interactions include diarrhoea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Gilotrif and Lantus. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Gilotrif?

Gilotrif has active ingredients of afatinib dimaleate. eHealthMe is studying from 6,055 Gilotrif users. Check the latest studies of Gilotrif.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

18 people who take Gilotrif and Lantus together, and have interactions are studied.

What are the common drug interactions of Gilotrif and Lantus, by gender? *:

female:

Diarrhoea
Stomatitis (inflammation of mucous membrane of mouth)
Nausea (feeling of having an urge to vomit)
Dehydration (dryness resulting from the removal of water)
Pruritus (severe itching of the skin)
Malaise (a feeling of general discomfort or uneasiness)
Alopecia (absence of hair from areas of the body)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Constipation
Corneal scar (nullah)

male:

Diarrhoea
Stomatitis (inflammation of mucous membrane of mouth)
Food intolerance (inability to have food)
Haemorrhage (bleeding)
Peripheral coldness
Pigmentation disorder (disturbances of human skin colour)
Pleural effusion (water on the lungs)
Surgery
Haematochezia (passage of stools containing blood)
Hypersensitivity

What are the common drug interactions of Gilotrif and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Diarrhoea
Stomatitis (inflammation of mucous membrane of mouth)
Decreased appetite
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Infection
Joint swelling
Pleural effusion (water on the lungs)
Pneumonia
Pruritus (severe itching of the skin)
Pulmonary embolism (blockage of the main artery of the lung)

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 11 people, 61.11%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 22.22%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 16.67%
High Blood Cholesterol: 1 person, 5.56%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.56%
Blood Pressure Abnormal: 1 person, 5.56%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.56%
Cancer Pain: 1 person, 5.56%
Dyspnea (difficult or laboured breathing): 1 person, 5.56%
Type 1 Diabetes: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Gilotrif and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously